Increased [qnco]
plasma concentration [qnco]
tgf-beta 1 [aapp, bacs]
hormone replacement [topp]
therapy [ftcn]
objectives [inpr]
Design [acty]
Hormone replacement therapy [topp]
postmenopausal [tmco]
Women [popg]
CARDIOVASCULAR [bdsy]
Dominant [ftcn]
Transforming Growth Factor beta [aapp, bacs]
Coronary Arteries [bpoc]
PROPOSED [idcn]
Lp(a) [aapp, bacs]
Lipoprotein [aapp, bacs]
Block [patf]
Activation [acty]
Latent [qlco]
tgf-beta 1 [aapp, bacs]
GIVEN [cnce]
Examined [fndg]
effects [qlco]
Hormone replacement therapy [topp]
tgf-beta 1 [aapp, bacs]
Lp(a) [aapp, bacs]
Lipoprotein [aapp, bacs]
postmenopausal [tmco]
Women [popg]
Women [popg]
Documented [hlca]
coronary heart disease [dsyn]
randomized [resa]
Sequential [idcn]
Transdermal [ftcn]
17 beta-Estradiol [horm, phsu, strd]
weeks [tmco]
Then [tmco]
Medroxyprogesterone [horm, phsu, strd]
days [tmco]
Hormone replacement therapy [topp]
Control Group [grup]
tgf-beta 1 [aapp, bacs]
Increased [qnco]
Hormone replacement therapy [topp]
Group [idcn]
Compared [acty]
c group [clas]
3 Months [tmco]
treatment [ftcn]
Sustained [ftcn]
months [tmco]
reduction [npop]
Lp(a) [aapp, bacs]
Lipoprotein [aapp, bacs]
3 Months [tmco]
treatment [ftcn]
Hormone replacement therapy [topp]
Group [idcn]
Compared [acty]
c group [clas]
months [tmco]
Lp(a) [aapp, bacs]
Lipoprotein [aapp, bacs]
Detected [fndg]
Group [idcn]
Novel [tmco]
Transdermal [ftcn]
17 beta-Estradiol [horm, phsu, strd]
postmenopausal [tmco]
Women [popg]
Levels [qlco]
tgf-beta 1 [aapp, bacs]
Concentration [menp]
Lp(a) [aapp, bacs]
Lipoprotein [aapp, bacs]
Suggest [idcn]
Mechanism [ftcn]
Hormone replacement therapy [topp]
Combination Therapy [topp]
Estradiol [horm, phsu, strd]
tgf-beta 1 [aapp, bacs]
Estradiol [horm, phsu, strd]
effects [qlco]
Lp(a) [aapp, bacs]
Lipoprotein [aapp, bacs]
